Upstream Bio, Inc.

US$3.23As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:UPBHealthcare
Country USA
PE (Fwd) •••
TSR 2Y CAGR (63.54%)
Div yield —
ROE (46.05%)
Biotechnology
Beta (5Y) 1.61
PE TTM —
TSR TTM (87.50%)
Mkt cap US$176.9M
ROIC (31.15%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$4.07
25.94%
92.65%
Hold 7|10|4|6|1
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.05
0.04
0.04
0.05
26.74%
19.79%
7.26%
13.84%
Revenue$M
20.16
20.80
20.51
20.59
11.02%
11.13%
4.67%
6.29%
Peers (US$176.9M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.288
0.173
0.142
EBIT/Intx
0.822
0.116
0.137
Own earn%
(84.61)
17.52
17.13
Sh yield%
20.12
56.24
54.95
Owners
Insiders/Inst%
0.57
26.24
Short interest%
4.33
SBC / revenue%
3.67
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
24–32
$1 testx
—
Incr. ROIC%
0